Consequently, the current research confirmed that suppression of survivin expression could evidently increase the chemosensitivity of laryngeal carcinoma cells to multiple drugs in hypoxic environments, which further demonstrated that survivin might partly take part in MDR induced by hypoxia in laryngeal carcinoma. The gene discussed is BIRC5; the disease is laryngeal carcinoma.